These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28401658)

  • 1. Kreuth IV: European consensus proposals for treatment of haemophilia with coagulation factor concentrates.
    Giangrande PLF; Peyvandi F; O'Mahony B; Behr-Gross ME; Hilger A; Schramm W; Mannucci PM
    Haemophilia; 2017 May; 23(3):370-375. PubMed ID: 28401658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kreuth III: European consensus proposals for treatment of haemophilia with coagulation factor concentrates.
    Giangrande P; Seitz R; Behr-Gross ME; Berger K; Hilger A; Klein H; Schramm W; Mannucci PM
    Haemophilia; 2014 May; 20(3):322-5. PubMed ID: 24731129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemophilia care in Europe: a survey of 19 countries.
    O'Mahony B; Noone D; Giangrande PL; Prihodova L
    Haemophilia; 2011 Jan; 17(1):35-40. PubMed ID: 20722746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
    Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
    Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kreuth V initiative: European consensus proposals for treatment of hemophilia using standard products, extended half-life coagulation factor concentrates and non-replacement therapies.
    Peyvandi F; Berger K; Seitz R; Hilger A; Hecquet ML; Wierer M; Buchheit KH; O'Mahony B; Bok A; Makris M; Mansmann U; Schramm W; Mannucci PM
    Haematologica; 2020 Aug; 105(8):2038-2043. PubMed ID: 32467138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry.
    Tengborn L; Baudo F; Huth-Kühne A; Knoebl P; Lévesque H; Marco P; Pellegrini F; Nemes L; Collins P;
    BJOG; 2012 Nov; 119(12):1529-37. PubMed ID: 22901076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of haemophilia A.
    Gringeri A; Muça-Perja M; Mangiafico L; von Mackensen S
    Expert Opin Biol Ther; 2011 Aug; 11(8):1039-53. PubMed ID: 21682657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing bleeds by treatment: new era for haemophilia changing the paradigm.
    Marijke van den Berg H
    Haemophilia; 2016 Jul; 22 Suppl 5():9-13. PubMed ID: 27405669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European principles of haemophilia care.
    Colvin BT; Astermark J; Fischer K; Gringeri A; Lassila R; Schramm W; Thomas A; Ingerslev J;
    Haemophilia; 2008 Mar; 14(2):361-74. PubMed ID: 18248408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis in the haemophilia population.
    Blanchette VS
    Haemophilia; 2010 Jul; 16 Suppl 5():181-8. PubMed ID: 20590879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel coagulation factor concentrates: issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patients.
    Ljung R; Auerswald G; Benson G; Jetter A; Jiménez-Yuste V; Lambert T; Morfini M; Remor E; Sørensen B; Salek SZ
    Haemophilia; 2013 Jul; 19(4):481-6. PubMed ID: 23387528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemophilia care in Europe: the ESCHQoL study.
    Schramm W; Gringeri A; Ljung R; Berger K; Crispin A; Bullinger M; Giangrande PL; Von Mackensen S; Mantovani LG; Nemes L; Serban M;
    Haemophilia; 2012 Sep; 18(5):729-37. PubMed ID: 22639833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Revision consensus hemophilia: treatment and responsibility. Nederlandse Vereniging van Hemophilia Patients].
    Briët E; Mauser-Bunschoten EP
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2566-71. PubMed ID: 9555158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors.
    Astermark J; Rocino A; Von Depka M; Van Den Berg HM; Gringeri A; Mantovani LG; Morado M; Garrido RP; Schiavoni M; Villar A; Windyga J;
    Haemophilia; 2007 Jan; 13(1):38-45. PubMed ID: 17212723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs.
    Santagostino E; Morfini M; Auerswald GK; Benson GM; Salek SZ; Lambert T; Salaj P; Jimenez-Yuste V; Ljung RC
    Haemophilia; 2009 Sep; 15(5):983-9. PubMed ID: 19712172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for individualizing haemophilia care.
    Sørensen B; Auerswald G; Benson G; Elezović I; Felder M; Lambert T; Morfini M; Remor E; Salaj P; Santagostino E; Šalek SZ; Ljung R
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):849-57. PubMed ID: 25396764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature.
    Caviglia H; Candela M; Galatro G; Neme D; Moretti N; Bianco RP
    Haemophilia; 2011 Nov; 17(6):910-9. PubMed ID: 21342367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing pattern of care of boys with haemophilia in western European centres.
    Chambost H; Ljung R;
    Haemophilia; 2005 Mar; 11(2):92-9. PubMed ID: 15810909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors in haemophilia A: current management and open issues.
    Haya S; Moret A; Cid AR; Cortina V; Casaña P; Cabrera N; Aznar JA
    Haemophilia; 2007 Dec; 13 Suppl 5():52-60. PubMed ID: 18078398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prophylaxis in patients with haemophilia complicated by inhibitors].
    Paweł Ł
    Pol Merkur Lekarski; 2011 Mar; 30(177):211-4. PubMed ID: 21545000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.